Literature DB >> 26633562

Syntheses and cellular investigations of di-aspartate and aspartate-lysine chlorin e(6) conjugates.

R G Waruna Jinadasa1, Zehua Zhou, M Graça H Vicente, Kevin M Smith.   

Abstract

Chlorin e6 is a tricarboxylic acid degradation product of chlorophyll a. Four chlorin e6 bis(amino acid) conjugates were regioselectively synthesized bearing two aspartate conjugates in the 13(1),17(3)- and 15(2),17(3)-positions, or at the 13(1),15(2)via an ethylene diamine linker. One additional conjugate bearing two different amino acids, lysine at 13(1)via an ethylene diamine linker and an aspartate at 15(2)via a β-alanine linker was also synthesized. The cytotoxicity and uptake of four di(amino acid) chlorin e6 conjugates were investigated in human HEp2 cells, and compared with chlorin e6. The most cytotoxic and most taken up conjugates were the zwitterionic 13(1),15(2)-disubstituted conjugates 28 and 33; these also localized in multiple organelles. In contrast, the anionic 13(1),17(3)- and 15(2),17(3)-di-aspartyl chlorin e6 conjugates 12 and 13 showed low dark cytoxicity and lower phototoxicity compared with chlorin e6.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26633562      PMCID: PMC4701634          DOI: 10.1039/c5ob02241j

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  32 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Photodynamic effect of novel chlorin e6 derivatives on a single nerve cell.

Authors:  A B Uzdensky; O Y Dergacheva; A A Zhavoronkova; A V Reshetnikov; G V Ponomarev
Journal:  Life Sci       Date:  2004-03-12       Impact factor: 5.037

3.  Outcome of photodynamic therapy using NPe6 for bronchogenic carcinomas in central airways >1.0 cm in diameter.

Authors:  Jitsuo Usuda; Shuji Ichinose; Taichirou Ishizumi; Hiroki Hayashi; Keishi Ohtani; Sachio Maehara; Shoutarou Ono; Hidetoshi Honda; Naohiro Kajiwara; Osamu Uchida; Hidemitsu Tsutsui; Tatsuo Ohira; Harubumi Kato; Norihiko Ikeda
Journal:  Clin Cancer Res       Date:  2010-03-23       Impact factor: 12.531

4.  Syntheses and cellular investigations of 17(3)-, 15(2)-, and 13(1)-amino acid derivatives of chlorin e(6).

Authors:  R G Waruna Jinadasa; Xiaoke Hu; M Graça H Vicente; Kevin M Smith
Journal:  J Med Chem       Date:  2011-10-07       Impact factor: 7.446

5.  Photosensitizers in clinical PDT.

Authors:  Ron R Allison; Gordon H Downie; Rosa Cuenca; Xin-Hua Hu; Carter Jh Childs; Claudio H Sibata
Journal:  Photodiagnosis Photodyn Ther       Date:  2004-05       Impact factor: 3.631

6.  In vitro characterization of monoaspartyl chlorin e6 and diaspartyl chlorin e6 for photodynamic therapy.

Authors:  W G Roberts; F Y Shiau; J S Nelson; K M Smith; M W Berns
Journal:  J Natl Cancer Inst       Date:  1988-05-04       Impact factor: 13.506

7.  Characterization of cutaneous photosensitivity in healthy volunteers receiving talaporfin sodium.

Authors:  Elizabeth Bromley; Brittany Briggs; Llew Keltner; Sy-Shi Wang
Journal:  Photodermatol Photoimmunol Photomed       Date:  2011-04       Impact factor: 3.135

8.  Management of multiple primary lung cancer in patients with centrally located early cancer lesions.

Authors:  Jitsuo Usuda; Shuji Ichinose; Taichirou Ishizumi; Hiroki Hayashi; Keishi Ohtani; Sachio Maehara; Shoutarou Ono; Naohiro Kajiwara; Osamu Uchida; Hidemitsu Tsutsui; Tatsuo Ohira; Harubumi Kato; Norihiko Ikeda
Journal:  J Thorac Oncol       Date:  2010-01       Impact factor: 15.609

9.  Experimental grounds for using chlorin e6 in the photodynamic therapy of malignant tumors.

Authors:  G A Kostenich; I N Zhuravkin; E A Zhavrid
Journal:  J Photochem Photobiol B       Date:  1994-03       Impact factor: 6.252

Review 10.  Photodynamic therapy.

Authors:  T J Dougherty; C J Gomer; B W Henderson; G Jori; D Kessel; M Korbelik; J Moan; Q Peng
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

View more
  7 in total

Review 1.  Use of Cyclodextrins in Anticancer Photodynamic Therapy Treatment.

Authors:  Amina Ben Mihoub; Ludivine Larue; Albert Moussaron; Zahraa Youssef; Ludovic Colombeau; Francis Baros; Céline Frochot; Régis Vanderesse; Samir Acherar
Journal:  Molecules       Date:  2018-08-02       Impact factor: 4.411

2.  Syntheses and PDT activity of new mono- and di-conjugated derivatives of chlorin e6.

Authors:  Hui Chen; Stewart W Humble; R G Waruna Jinadasa; Zehua Zhou; Alex L Nguyen; M Graça H Vicente; Kevin M Smith
Journal:  J Porphyr Phthalocyanines       Date:  2017 Apr-Jun       Impact factor: 1.811

3.  Flexible synthesis of cationic peptide-porphyrin derivatives for light-triggered drug delivery and photodynamic therapy.

Authors:  R Dondi; E Yaghini; K M Tewari; L Wang; F Giuntini; M Loizidou; A J MacRobert; I M Eggleston
Journal:  Org Biomol Chem       Date:  2016-12-07       Impact factor: 3.876

4.  PEGylated Purpurin 18 with Improved Solubility: Potent Compounds for Photodynamic Therapy of Cancer.

Authors:  Vladimíra Pavlíčková; Silvie Rimpelová; Michal Jurášek; Kamil Záruba; Jan Fähnrich; Ivana Křížová; Jiří Bejček; Zdeňka Rottnerová; Vojtěch Spiwok; Pavel Drašar; Tomáš Ruml
Journal:  Molecules       Date:  2019-12-06       Impact factor: 4.411

Review 5.  Photoinduced Endosomal Escape Mechanism: A View from Photochemical Internalization Mediated by CPP-Photosensitizer Conjugates.

Authors:  Tet Htut Soe; Kazunori Watanabe; Takashi Ohtsuki
Journal:  Molecules       Date:  2020-12-23       Impact factor: 4.411

6.  Endolysosomal targeting of a clinical chlorin photosensitiser for light-triggered delivery of nano-sized medicines.

Authors:  Elnaz Yaghini; Ruggero Dondi; Kunal M Tewari; Marilena Loizidou; Ian M Eggleston; Alexander J MacRobert
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

Review 7.  An updated overview on the development of new photosensitizers for anticancer photodynamic therapy.

Authors:  Juan Zhang; Chengshi Jiang; João Paulo Figueiró Longo; Ricardo Bentes Azevedo; Hua Zhang; Luis Alexandre Muehlmann
Journal:  Acta Pharm Sin B       Date:  2017-09-22       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.